Last10K.com

Acro Biomedical Co., Ltd. (ACBM) SEC Filing 10-K Annual report for the fiscal year ending Saturday, September 30, 2017

Acro Biomedical Co., Ltd.

CIK: 1622996 Ticker: ACBM

View differences made from one year to another to evaluate Acro Biomedical Co., Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acro Biomedical Co., Ltd..

Continue

Assess how Acro Biomedical Co., Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acro Biomedical Co., Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Acro Biomedical Co., Ltd. provided additional information to their SEC Filing as exhibits

Ticker: ACBM
CIK: 1622996
Form Type: 10-K Annual Report
Accession Number: 0001640334-18-000094
Submitted to the SEC: Tue Jan 16 2018 3:55:30 PM EST
Accepted by the SEC: Tue Jan 16 2018
Period: Saturday, September 30, 2017
Industry: Amusement And Recreation Services

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/acbm/0001640334-18-000094.htm